234 related articles for article (PubMed ID: 20418469)
1. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
2. Expression of KIT receptor in feline cutaneous mast cell tumors.
Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characterization of feline mast cell tumors.
Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
5. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
6. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
7. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
[TBL] [Abstract][Full Text] [Related]
10. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas.
Smith AJ; Njaa BL; Lamm CG
Vet Pathol; 2009 Sep; 46(5):934-9. PubMed ID: 19429996
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
15. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.
Preziosi R; Sarli G; Paltrinieri M
J Comp Pathol; 2004; 130(2-3):143-51. PubMed ID: 15003472
[TBL] [Abstract][Full Text] [Related]
17. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
Preziosi R; Morini M; Sarli G
J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
19. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous mast cell neoplasia in cats: 14 cases (1975-1985).
Buerger RG; Scott DW
J Am Vet Med Assoc; 1987 Jun; 190(11):1440-4. PubMed ID: 3112049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
